|
| Press Releases |
|
 |
|
| Thursday, May 2, 2024 |
|
|
Q&M Dental Enhances Digital Capabilities by Integrating Align Technology's Newest iTero Lumina(TM) Intraoral Scanner Across Dental Clinics in Singapore |
| Mainboard listed Q&M Dental Group (Singapore) Limited ("Q&M" or "the Company" and together with its subsidiaries, the "Group") is proud to announce its integration of Align Technology's ("Align") iTero Lumina(TM) Intraoral Scanner in Singapore. more info >> |
|
| Tuesday, April 23, 2024 |
|
|
EM2AI Revolutionising the Dental Industry: New AI Products Promise Transparent Treatment Plans for Patients |
| EM2AI Pte. Ltd., ("EM2AI" or the "Company") an Artificial Intelligence (AI) dental healthcare company based in Singapore today announced a groundbreaking development poised to reshape the landscape of dental care, with the launch of its pioneering dental AI product. more info >> |
|
| Friday, March 3, 2023 |
|
|
CATALIST-listed AOXIN Q&M reports lower revenue of RMB 140m for full year ended 31 December 2022 |
| Catalist listed Aoxin Q&M Dental Limited, announced on 1 March 2023, a 12.8% lower revenue of RMB139.7 million for full year ended 31 December 2022 (FY2022). The Group reported a net loss after tax excluding impairment loss on investment in our associate of RMB7.3 million for FY2022, primarily due to the number of shutdowns from China's zero-Covid policy that was in place all the way up until 8 January 2023. more info >> |
|
| Wednesday, February 23, 2022 |
|
|
CATALIST-listed AOXIN Q&M records 21% growth in revenue for full year ended 31 December 2021 |
| Catalist listed Aoxin Q&M Dental Limited ("Aoxin" or "the Group"), today announced a 20.8% increase in revenue to RMB160.2 million for full year ended 31 December 2021 ("FY2021"). more info >> |
|
| Monday, October 4, 2021 |
|
|
Aoxin Q & M acquires 49% stake in Acumen Diagnostics for S$29.4m |
| Aoxin Q & M Dental Group Ltd (SGX: 1D4.SI) ("Aoxin Q & M") and Q & M Dental Group (Singapore) Limited (SGX: QC7.SI) ("Q & M"), announced today that Aoxin Q & M will acquire 49% of Acumen Diagnostics Pte. Ltd. ("Acumen Diagnostics") for a consideration of S$29.4 million. Acumen Diagnostics has a preliminary valuation of S$60 million. more info >> |
|
|
|
|
|
|
|
|
|
| Latest Press Releases |
|
18th Asian Financial Forum wraps up successfully
Jan 15, 2025 14:10 JST
|
|
|
YESIANG Enterprise、革新的なグリーン技術でグローバルな持続可能性推進をリード
Jan 15, 2025 13:00: JST
|
|
|
Fujitsu, Resona Bank and Saitama Resona Bank launch new web service to simplify home-buying process
Jan 15, 2025 13:13 JST
|
|
|
三菱重工、東京都交通局の日暮里・舎人ライナー向けで330形車両12編成（60両）を完納
Jan 15, 2025 10:30: JST
|
|
|
TANAKA's Group Company EEJA to Exhibit at 39th NEPCON JAPAN
Jan 15, 2025 11:00 JST
|
|
|
FDA Accepts LEQEMBI (lecanemab-irmb) Biologics License Application for Subcutaneous Maintenance Dosing for the Treatment of Early Alzheimer's Disease
Jan 15, 2025 10:03 JST
|
|
|
Bedding Industries of America Unveils Glacier: The Ultimate Hybrid Cooling Mattress
Jan 15, 2025 00:42: JST
|
|
|
Bedding Industries of America Unveils Glacier: The Ultimate Hybrid Cooling Mattress
Jan 14, 2025 23:42 HKT/SGT
|
|
|
富士通、「コーポレートガバナンス・オブ・ザ・イヤー2024」で「Grand Prize Company（大賞）」を受賞
Jan 14, 2025 13:40: JST
|
|
|
Swiss WEB3FEST Winter Edition 2025
Jan 14, 2025 11:01 HKT/SGT
|
|
|
One-Hour Payouts: Hola Prime Solves Prop Trading's Biggest Problem
Jan 14, 2025 11:00: JST
|
|
|
One-Hour Payouts: Hola Prime Solves Prop Trading's Biggest Problem
Jan 14, 2025 10:00 HKT/SGT
|
|
|
エーザイとバイオジェン・インク、早期アルツハイマー病治療剤「レケンビ(R)」の皮下注射製剤維持投与に関する 生物製剤承認申請を米国FDAが受理
Jan 14, 2025 10:00: JST
|
|
|
Investing in Tomorrow: Winvest Group Opens Up Metaverse Opportunities
Jan 13, 2025 23:00: JST
|
|
|
Investing in Tomorrow: Winvest Group Opens Up Metaverse Opportunities
Jan 13, 2025 23:00 HKT/SGT
|
|
|
|
|
More News >> |
|
|
|
|
|
